Jason Bock, Ph.D., has spent the last 20 years in small, medium and large biotech and biopharma companies developing biologic therapeutics. He has brought 15 novel drugs through preclinical development into clinical studies, as well as driven three biologics through the clinic to commercialization globally. He is excited to use his experience to build the Biologics Development team within Therapeutics Discovery to synergize the innovative basic research to world-class clinicians at MD Anderson.